Cadila Healthcare's Company Signs 3 Share Purchase Agreements To Acquire Amplitude Surgical, Eyes Over 90 per cent Ownership Through Block Deal And Tender Offer
Cadila Healthcare's Company Signs 3 Share Purchase Agreements To Acquire Amplitude Surgical, Eyes Over 90 per cent Ownership Through Block Deal And Tender Offer

Cadila Healthcare's Company Signs 3 Share Purchase Agreements To Acquire Amplitude Surgical, Eyes Over 90 per cent Ownership Through Block Deal And Tender Offer

In a year, the stock has declined by 8 per cent while in last 3 years the stock has jumped by 151 per cent.

DSIJ Intelligence-2 Article rating: 5.0

In a year, the stock has declined by 8 per cent while in last 3 years the stock has jumped by 151 per cent.

This Lifesciences Company Secures USFDA Approval for Eluxadoline Tablets with 180-Day Exclusivity; Stock Price Logged 135.25 per cent Returns in 3 years
This Lifesciences Company Secures USFDA Approval for Eluxadoline Tablets with 180-Day Exclusivity; Stock Price Logged 135.25 per cent Returns in 3 years

This Lifesciences Company Secures USFDA Approval for Eluxadoline Tablets with 180-Day Exclusivity; Stock Price Logged 135.25 per cent Returns in 3 years

With a PE ratio of 20x, the company trades at a discount compared to the industry PE of 28x. The company has ROCE of 22.3 per cent and ROE of 20.7 per cent.  

DSIJ Intelligence-2 Article rating: 5.0

DSIJ MINDSHARE

Mkt Commentary16-May, 2025

Mindshare18-May, 2025

Multibaggers18-May, 2025

Mindshare18-May, 2025

Penny Stocks18-May, 2025

Knowledge

MF15-May, 2025

MF2-May, 2025

MF30-Apr, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR